PAQ Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$77M
- Investors
-
12
PAQ Therapeutics General Information
Description
Operator of a biotechnology company intended to restore health and cure disease through autophagy. The company develops a novel class of small-molecule degraders through autophagosome-tethering compound technology capable of binding a diverse array of substrates to the autophagy pathway, enabling physicians to create cures and overcome serious diseases where therapeutic options are limited for patients.
Contact Information
Website
www.paqtx.comCorporate Office
- 625 Mass Avenue
- Office 02-146
- Cambridge, MA 02139
- United States
Corporate Office
- 625 Mass Avenue
- Office 02-146
- Cambridge, MA 02139
- United States
PAQ Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B) | 22-Jan-2026 | $77M | Completed | Generating Revenue | ||
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Early Stage VC (Series A) | 15-Jul-2021 | $30M | $34M | Completed | Generating Revenue | |
| 1. Seed Round | 08-Nov-2020 | $4M | $4M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
PAQ Therapeutics Comparisons
Industry
Financing
Details
PAQ Therapeutics Competitors (73)
One of PAQ Therapeutics’s 73 competitors is Neurogene, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neurogene | Formerly VC-backed | New York, NY | ||||
| Cerecin | Venture Capital-Backed | Broomfield, CO | ||||
| Kymera Therapeutics | Formerly VC-backed | Watertown, MA | ||||
| Asceneuron | Venture Capital-Backed | Eysins, Switzerland | ||||
| TauRx Pharmaceuticals | Private Equity-Backed | Aberdeen, United Kingdom |
PAQ Therapeutics Patents
PAQ Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024355429-A1 | Kras proteolysis targeting chimeras | Pending | 03-Oct-2023 | ||
| EP-4788683-A1 | Kras proteolysis targeting chimeras | Pending | 03-Oct-2023 | ||
| US-12599672-B2 | Kras proteolysis targeting chimeras | Active | 03-Oct-2023 | ||
| US-20250144225-A1 | Kras proteolysis targeting chimeras | Active | 03-Oct-2023 | ||
| WO-2025076044-A1 | Kras proteolysis targeting chimeras | Inactive | 03-Oct-2023 | A61K47/55 |
PAQ Therapeutics Signals
PAQ Therapeutics Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bayland Capital | Corporate Venture Capital | Minority | ||
| BioTrack Capital | Venture Capital | Minority | ||
| Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | Minority | ||
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority | ||
| LAV Fund | Corporation | Minority |
PAQ Therapeutics FAQs
-
When was PAQ Therapeutics founded?
PAQ Therapeutics was founded in 2020.
-
Where is PAQ Therapeutics headquartered?
PAQ Therapeutics is headquartered in Cambridge, MA.
-
What is the size of PAQ Therapeutics?
PAQ Therapeutics has 10 total employees.
-
What industry is PAQ Therapeutics in?
PAQ Therapeutics’s primary industry is Drug Discovery.
-
Is PAQ Therapeutics a private or public company?
PAQ Therapeutics is a Private company.
-
What is PAQ Therapeutics’s current revenue?
The current revenue for PAQ Therapeutics is .
-
How much funding has PAQ Therapeutics raised over time?
PAQ Therapeutics has raised $111M.
-
Who are PAQ Therapeutics’s investors?
Bayland Capital, BioTrack Capital, Johnson & Johnson Innovation - JLABS, Johnson & Johnson JJDC, and LAV Fund are 5 of 12 investors who have invested in PAQ Therapeutics.
-
Who are PAQ Therapeutics’s competitors?
Neurogene, Cerecin, Kymera Therapeutics, Asceneuron, and TauRx Pharmaceuticals are some of the 73 competitors of PAQ Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process